Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
diabetes
2
×
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amgen
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
bessemer venture partners
biotech ipos
bolt biotherapeutics
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer
cell therapy
cidara therapeutics
cigna
clinical trials
concert pharmaceuticals
cvs health
detroit blog main
detroit top stories
diabetes type 2
diagnostics
eculizumab
entresto
european society of cardiology
What
type
2
×
advantages
associates
bar
based
bessemer
bio
brings
capital
catalyst
deerfield
develop
developing
diabetes
domain
drug
emergent
expect
financing
firms
fractyl
fund
gamble
general
gv
ido
including
l.p
labs
lexington
management
market
massachusetts
medco’s
medical
million
mithril
mover
new
partners
Language
unset
Current search:
type
×
diabetes
×
biotech
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@techcrunch.com
6 years ago
Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes
